Nektar Therapeutics Takes Over #53 Spot From Leggett & Platt
July 06, 2018 at 11:49 AM EDT
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Nektar Therapeutics (NKTR) has taken over the #53 spot from Leggett & Platt, Inc. (LEG), according to ETF Channel..
